Health benefits of combined oral contraceptives - a narrative review.
Coelingh Bennink HJT, van Gennip FAM, Gerrits MGF, Egberts JFM, Gemzell-Danielsson K, Kopp-Kallner H.
Eur J Contracept Reprod Health Care. 2024 Apr;29(2):40-52. doi: 10.1080/13625187.2024.2317295. Epub 2024 Mar 1.
PMID:38426312
Contraception for women with multiple sclerosis: Guidance for healthcare providers.
Houtchens MK, Zapata LB, Curtis KM, Whiteman MK.
Mult Scler. 2017 May;23(6):757-764. doi: 10.1177/1352458517701314. Epub 2017 Mar 24.
PMID:28338393
Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies.
Iyer P, Dobson R.
Neurol Ther. 2023 Feb;12(1):1-10. doi: 10.1007/s40120-022-00421-0. Epub 2022 Nov 28.
PMID:36443593
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.
Gavoille A, Rollot F, Casey R, Mathey G, Le Page E, Ciron J, De Sèze J, Ruet A, Maillart E, Labauge P, Zephir H, Kwiatkowski A, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Dubessy AL, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al-Khedr A, Casez O, Bourre B, Wahab A, Magy L, Moulin S, Camdessanché JP, Doghri I, Sarov-Riviere M, Hankiewicz K, Pottier C, Dos Santos A, Nifle C, Subtil F, Vukusic S; OFSEP Investigators.
JAMA Neurol. 2025 Aug 4:e252550. doi: 10.1001/jamaneurol.2025.2550. Online ahead of print.
PMID:40758347
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.
Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.
Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.
PMID:29438041
Pregnancy and multiple sclerosis: the children of PRIMS.